Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Identification of Excipients for Stabilizing Fiberless Adenovirus as Biopharmaceuticals.

Kupgan G, Choudhari SP, Flynn NH, Nigatu A, Vupputuri S, Picking WL, Picking WD, Ramsey JD.

J Pharm Sci. 2017 Jul;106(7):1764-1771. doi: 10.1016/j.xphs.2017.04.013. Epub 2017 Apr 18.

PMID:
28427886
2.

Biophysical Characterization of the Type III Secretion System Translocator Proteins and the Translocator Proteins Attached to Bacterium-Like Particles.

Chen X, Choudhari SP, Kumar P, Toth RT 4th, Kim JH, Van Roosmalen ML, Leenhouts K, Middaugh CR, Picking WL, Picking WD.

J Pharm Sci. 2015 Dec;104(12):4065-4073. doi: 10.1002/jps.24659. Epub 2015 Sep 30.

PMID:
26422758
3.

Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Chen X, Choudhari SP, Martinez-Becerra FJ, Kim JH, Dickenson NE, Toth RT 4th, Joshi SB, Greenwood JC 2nd, Clements JD, Picking WD, Middaugh CR, Picking WL.

Infect Immun. 2015 Jan;83(1):292-9. doi: 10.1128/IAI.02457-14. Epub 2014 Nov 3.

4.

Biophysical characterization of the type III secretion tip proteins and the tip proteins attached to bacterium-like particles.

Choudhari SP, Chen X, Kim JH, Van Roosmalen ML, Greenwood JC 2nd, Joshi SB, Picking WD, Leenhouts K, Middaugh CR, Picking WL.

J Pharm Sci. 2015 Feb;104(2):424-32. doi: 10.1002/jps.24047. Epub 2014 Jun 10.

5.

Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.

Infect Immun. 2013 Dec;81(12):4470-7. doi: 10.1128/IAI.00859-13. Epub 2013 Sep 23.

6.

A systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccine.

Choudhari SP, Pendleton KP, Ramsey JD, Blanchard TG, Picking WD.

J Pharm Sci. 2013 Aug;102(8):2508-19. doi: 10.1002/jps.23643. Epub 2013 Jun 21.

7.

Three functional β-carbonic anhydrases in Pseudomonas aeruginosa PAO1: role in survival in ambient air.

Lotlikar SR, Hnatusko S, Dickenson NE, Choudhari SP, Picking WL, Patrauchan MA.

Microbiology. 2013 Aug;159(Pt 8):1748-59. doi: 10.1099/mic.0.066357-0. Epub 2013 May 31.

8.

Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Heine SJ, Diaz-McNair J, Martinez-Becerra FJ, Choudhari SP, Clements JD, Picking WL, Pasetti MF.

Vaccine. 2013 Jun 19;31(28):2919-29. doi: 10.1016/j.vaccine.2013.04.045. Epub 2013 May 2.

9.

Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella.

Martinez-Becerra FJ, Scobey M, Harrison K, Choudhari SP, Quick AM, Joshi SB, Middaugh CR, Picking WL.

Vaccine. 2013 May 31;31(24):2667-72. doi: 10.1016/j.vaccine.2013.04.012. Epub 2013 Apr 16.

PMID:
23602665
10.

Studies of the conformational stability of invasion plasmid antigen B from Shigella.

Choudhari SP, Kramer R, Barta ML, Greenwood JC 2nd, Geisbrecht BV, Joshi SB, Picking WD, Middaugh CR, Picking WL.

Protein Sci. 2013 May;22(5):666-70. doi: 10.1002/pro.2249. Epub 2013 Mar 26.

11.

Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon.

Dickenson NE, Choudhari SP, Adam PR, Kramer RM, Joshi SB, Middaugh CR, Picking WL, Picking WD.

Protein Sci. 2013 May;22(5):614-27. doi: 10.1002/pro.2245. Epub 2013 Mar 18.

12.

Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Martinez-Becerra FJ, Kissmann JM, Diaz-McNair J, Choudhari SP, Quick AM, Mellado-Sanchez G, Clements JD, Pasetti MF, Picking WL.

Infect Immun. 2012 Mar;80(3):1222-31. doi: 10.1128/IAI.06174-11. Epub 2011 Dec 27.

Supplemental Content

Loading ...
Support Center